Special Issue: Pharmacy Benefits

Treatment Patterns Among Adults With ADHD Receiving Long-Acting Therapy

July 13, 2018

WEB EXCLUSIVE

Adults with attention-deficit/hyperactivity disorder (ADHD) who received long-acting combination therapy had significantly lower adherence and persistence compared with those who received long-acting monotherapy.

5-ASA to Sulfasalazine Drug Switch Program in Patients With Ulcerative Colitis

July 11, 2018

WEB EXCLUSIVE

A 5-aminosalicylic acid (5-ASA) drug switch program switching from 5-ASA to sulfasalazine was instituted for insured patients with ulcerative colitis. Unanticipated barriers limited the number of patients who switched, but significant cost savings were still obtained.

A Gray Area for Reimbursement: Medical Foods for Non–Inborn Errors of Metabolism

July 10, 2018

WEB EXCLUSIVE

Most non–inborn errors of metabolism (non-IEM) medical foods (MFs) do not meet the regulatory MF definition and lack scientific evidence for safety and efficacy. Non-IEM MFs are not yet ready for reimbursement by public insurers.